The role of tumour necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system

Progress in Neurobiology

Volumn 56, Issue 3, 1998, Pages 307-340

  Angeles Muñoz Fernández, Ma ^a   Fresno, Manuel ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN PROTECTION; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOKINE PRODUCTION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL ADHESION MOLECULES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; NERVOUS SYSTEM DISEASES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, CYTOKINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344157469     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(98)00045-8     Document Type: Review

References (454)

1. Adamson D. C., Wildemann B., Sasaki M., Glass J. D., McArthur J. C., Christov V. I., Dawson T. M., Dawson V. L. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science. 274:1996;1917-1921.
2. Aderka D., Engelmann H., Maor Y., Brakebusch C., Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175:1992;323-329.
3. Aggarwal, B. B. (1991) Comparative analysis of the structure and function of TNF-α and TNF-β. In: Tumor Necrosis Factors. Structure, Function and Mechanism of Action, pp. 61-78. Eds. B. B. Aggarwal and J. Vilcek. Marcel Dekker, New York.
4. Akaneyra Y., Takahashi M., Hatanaka H. Interleukin-1 β enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp. Neurol. 136:1995;44-52.
5. Akassoglou K., Probert L., Kontogeorgos G., Kollias G. Astrocyte- but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the CNS of transgenic mice. J. Immunol. 158:1997;438-445.
6. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1993;1-78.
7. Aloisi F., Care A., Borsellino G., Gallo P., Rosa S., Bassani A., Testa U., Levi G., Peschle C. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1β and tumor necrosis factor-α J. Immunol. 149:1992;2358-2366.
8. An S. F., Scaravilli F. Early HIV-1 infection of the central nervous system. Arch. Anat. Cytol. Pathol. 45:1997;94-105.
9. Andersson P. B., Perry V. H., Gordon S. Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the CNS. J. Exp. Med. 176:1992;255-259.
10. Araujo, D. M. (1992) Contrasting effects of specific lymphokines on the survival of hippocampal neurones in culture. In: Treatment of Dementias, pp. 113-122, Ed. E. Myer. Plenum Press, New York.
11. Archelos J. J., Jung S., Maurer M., Schmied M., Lassmann H., Tamatani T., Miyasaka M., Toyka K. V., Hartung H. P. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann. Neurol. 34:1993;145-154.
12. Arwin B., Neville L. F., Barone F. C., Feuerstein G. Z. The role of inflammation and cytokines in brain injury. Neurosci. Biobehav. 20:1996;445-452.
13. Bach E. A., Aguet M., Schriber R. D. The IFNγ receptor: a paradigm for cytokine receptor signaling. A. Rev. Immunol. 15:1997;563-591.
14. Baeuerle P. A., Henkel T. Function and activation of NF-κB in the immune system. A. Rev. Immunol. 12:1994;141-179.
15. Bagasra O., Michaels F. H., Zheng Y. M., Bobroski L. E., Spitsin S. V., Fu Z. F., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. natl Acad. Sci. U.S.A. 92:1995;12041-12055.
16. Baker D., Butler D., Scallon B. J., O'Neill J. K., Turk J. L., Feldmann M. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24:1994;2040-2048.
17. Baldwin A. S. Jr. The NF-κB and IκB proteins: new discoveries and insights. A. Rev. Immunol. 14:1996;649-681.
18. Ballestas M. E., Benveniste E. N. Interleukin-1β and tumor necrosis factor-α mediated regulation of ICAM-1 gene expression in astrocytes requires protein kinase C activity. Glia. 14:1995;267-278.
19. Banks W. A., Kastin A. J., Durham D. A. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res. Bull. 23:1989;433-437.
20. 2+ accumulation. Proc. natl Acad. Sci. U.S.A. 92:1995;9328-9332.
21. Barish M., Mansdorf N. B., Raissdana S. S. Gamma-interferon promotes differentiation of cultured cortical and hippocampal neurons. Dev. Biol. 144:1991;412-423.
22. Barna B. P., Estes M. L., Jacobs B. S., Hudson S., Ransohof R. M. Human astrocytes proliferate in response to tumor necrosis factor alpha. J. Neuroimmunol. 30:1990;239-243.
23. Baron J. L., Madri J. A., Ruddle N. H., Hashim G., Janeway C. A. Jr. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
24. Barten D. M., Ruddle N. H. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 51:1994;123-133.
25. Bauer J., Strauss S., Schriter-Gasser U., Ganter U., Schlegel P., Witt I., Yolk B., Berger M. Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 284:1991;111-114.
26. Bazzoni F., Beutler B. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1996;1717-1725.
27. Beck J., Rondot P., Catinot L., Falcoff E., Kirchner H., Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestations in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78:1988;318-323.
28. Beg A. A., Baltimore D. An assential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
29. Belman A. L. HIV-1-associated CNS disease in infants and children. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 72:1994;289-310.
30. + exchange in astrocytes. J. Biol. Chem. 269:1994;13811-13816.
31. Benveniste, E. N. (1994) Cytokine circuits in brain: implications for AIDS dementia complex. In: HIV, AIDS, and the Brain, pp. 71-88. Eds R. W. Price and S. W. Perry. Raven Press, New York.
32. Benveniste E. N., Sparacio S. M., Bethea J. R. Tumor necrosis factor-α enhances interferon-γ mediated Class II antigen expression on astrocytes. J. Neuroimmunol. 25:1989;209-215.
33. Benveniste E. N., Sparacio S. M., Norris J. G., Grenett H. E., Fuller G. M. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30:1990;201-212.
34. Benveniste E. N., Kwon J., Chung W. J., Sampson J., Pandya L., Tang L. P. Differential modulation of astrocyte cytokine gene expression by TGF-β J. Immunol. 153:1994;5210-5221.
35. Benveniste E. N., Huneycutt B. S., Shrikant P., Ballestas M. E. Second messenger systems in the regulation of cytokines and adhesion molecules in the central nervous system. Brain Behav. Immun. 9:1995;304-314.
36. Benveniste E. N., Tang L. P., Law R. M. Differential regulation of astrocyte TNF-α expression by the cytokines TGF-β, IL-6 and IL-10. Int. J. Dev. Neurosci. 13:1995;341-349.
37. Bethea J. R., Gillespie G. Y., Chung I. Y., Benveniste E. N. Tumor necrosis factor production and receptor expression by a human astroglioma cell line. J. Neuroimmunol. 30:1990;1-13.
38. Billiau A. Interferon-γ: biology and role in pathogenesis. Adv. Immunol. 62:1996;61-130.
39. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J. Immunol. 140:1988;1506-1510.
40. Birdsall H. H., Lane C., Ramser M. N., Anderson D. C. Induction of VCAM-1 and ICAM-1 on human neural cells and mechanisms of mononuclear leukocyte adherence. J. Immunol. 148:1992;2717-2723.
41. Blatteis, C. M. (1992) Role of the OVLT in the febrile response to circulating pyrogenes. In: Progress in Brain Research, Vol. 91, pp. 409-412, Eds. A. Ermisch, R. Landgraf and H. J. V. Ruehle. Elsevier Science, Amsterdam.
42. Blottner D., Grozdanovic Z., Gossrau R. Histochemistry of the nitric oxide synthase in the nervous system. Histiochem. J. 27:1995;785-811.
43. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202:1995;17-20.
44. Bo L., Dawson T. M., Wesselingh S., Mork S., Choi S., Kong P. A., Hanley D., Trapp B. D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brain. Ann. Neurol. 36:1994;778-786.
45. Boehm U., Klamp T., Groot M., Howard J. C. Cellular responses to interferon-γ A. Rev. Immunol. 15:1997;749-795.
46. Boje K. M., Arora P. K. Microglial produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
47. Bolaños J. P., Medina J. M. Induction of nitric oxide synthase inhibits gap junction permeability in cultured rat astrocytes. J. Neurochem. 66:1996;2091-2099.
48. Bolaños J. P., Peuchen S., Heales S. J. R., Land J. M., Clark J. B. Nitric oxide-mediated inhibition of themitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63:1994;910-916.
49. Bolin L. M., Verity A. N., Silver J. E., Shooter E. M., Abrams J. S. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J. Neurochem. 64:1995;850-858.
50. Bonetti B., Raine C. S. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42:1997;74-84.
51. Braun N., Michel U., Ernst B. P., Metzner R., Bitsch A., Weber F., Rieckmann P. Gene polymorphism at position-308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neurosci. Lett. 215:1996;75-78.
52. Breder C. D., Tsujimoto M., Terano Y., Scott D. W., Saper C. B. Distribution and characterization of tumor necrosis factor-α-like immunoreactivity in the murine central nervous system. J. Comp. Neurol. 337:1993;543-567.
53. Bredt D. S., Snyder S. H. Nitric oxide: a physiologic messenger molecule. A. Rev. Biochem. 63:1994;175-195.
54. Brenman J. E., Bredt D. S. Synaptic signaling by nitric oxide. Curr. Opin. Neurobiol. 7:1997;374-378.
55. Brenneman D. E., Weatbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R., Pert C. B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 335:1988;639-642.
56. Brenneman D. E., Schultzberg M., Bartfai T., Gozes I. Cytokine regulation of neuronal survival. J. Neurochem. 58:1992;454-460.
57. Brenner T., Brocke S., Szafer F., Sobel R. A., Parkinson J. F., Perez D. H., Steinman L. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158:1997;2940-2946.
58. Brett J., Gerlach H., Nawroth P., Steinberg S., Godman G., Stern D. Tumor necrosis factor cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J. Exp. Med. 169:1989;1977-1991.
59. Brew B., Rosenblum M., Cronin K., Price R. The AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann. Neurol. 38:1995;563-570.
60. Brosnan C. F., Battistini L., Raine C. S., Dickson D. W., Casadevall A., Lee S. C. Reactive nitrogen intermediates in human neuropathology: an overview. Dev. Neurosci. 16:1994;152-161.
61. Brosnan C. F., Lee S. C., Liu J. Regulation of inducible nitric oxide synthase expression in human glia: implications for inflammatory central nervous system diseases. Biochem. Soc. Trans. 25:1997;679-683.
62. Bruce A. J., Boling W., Kindy M. S., Peschon J., Kraemer P. J., Carpenter M. K., Holtsberg F. W., Mattson M. P. Altered neuronal and microglial responses to excitotoxic and ischaemic brain injury in mice lacking TNF receptors. Nature Med. 2:1996;788-794.
63. Budka H. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol. 77:1989;225-236.
64. Bukrinsky M. I., Nottet H. S. L. M., Schmidtmayerova H., Dubrovsky L., Flanagan C. R., Mullins M. E., Lipton S. A., Genderman H. E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J. Exp. Med. 181:1995;735-745.
65. Burns T. M., Clough J. A., Klein R. M., Wood G. W., Berman N. E. Developmental regulation of cytokine expression in the mouse brain. Growth Factors. 9:1993;253-258.
66. Campbell I. L., Abraham C. R., Masliah E., Kemper P., Inglis J. D., Oldstone M. B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. natl Acad. Sci. U.S.A. 90:1993;10061-10065.
67. Campbell I. L., Hobbs M. V., Kemper P., Oldstone M. B. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J. Immunol. 152:1994;716-723.
68. Campbell I. L., Stalder A. K., Chiang C. S., Bellinger R., Heyser C. J., Steffensen S., Masliah E., Powell H. C., Gold L. H., Henriksen S. J., Siggins G. R. Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol. Psychiatry. 2:1997;125-129.
69. Cannella B., Raine C. S. Cytokines up-regulate Ia expression in organotypic cultures of central nervous system tissue. J. Neuroimmunol. 24:1989;239-248.
70. Cannella B. C., Raine C. S. The adhesion molecules and cytokine profile of multile sclerosis lesion. Ann. Neurol. 37:1995;424-435.
71. Cannella B., Cross A. H., Raine C. S. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J. Exp. Med. 172:1990;1521-1524.
72. Cannella B., Cross A. H., Riane C. S. Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 46:1993;43-55.
73. Cannella B., Sizing I. D., Benjamin C. D., Browning J. L., Raine C. S. Antibodies to lymphotoxin alpha (LT alpha) and LT beta recognize different glial cell types in the central nervous system. J. Neuroimmunol. 78:1997;172-179.
74. Carman-Krzan M., Vige X., Wise B. C. Regulation by interleukin-1 of nerve growth factor secretion and nerve growth factor mRNA expression in rat primary astroglial cultures. J. Neurochem. 56:1991;636-643.
75. Carter B. V., Lewin G. R. Neurotrophins live or let die: does p75 NTR decide? Neuron. 18:1997;187-190.
76. de Caterina R., Libby P., Peng H. B., Thannickal V. J., Rajavashisth T. B., Gimbrone M. A., Shin W. S., Liao J. K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:1995;60-68.
77. Chang J. Y., Martin D. P., Johnson E. M. Jr. Interferon suppresses sympathetic neuronal cell death caused by nerve growth factor deprivation. J. Neurochem. 55:1990;436-445.
78. Chao C. C., Hu S., Molitor T. W., Shaskan E. G., Peterson P. K. Activated microglia mediated neuronal cell death injury via a nitric oxide mechanism. J. Immunol. 149:1992;2736-2741.
79. Chao C. C., Hu S., Ehrlich L., Peterson P. K. Interleukin-1 and tumor necrosis factor-α synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav. Immun. 9:1995;355-365.
80. Chao C. C., Hu S., Sheng W. S., Bu D., Bukrinsky M. I., Peterson P. K. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia. 16:1996;276-284.
81. Chen P., Mayne M., Power Ch., Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-α production. J. Biol. Chem. 272:1997;22385-22388.
82. Cheng B., Christakos S., Mattson M. P. Tumor necrosis factor protects neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron. 12:1994;139-153.
83. Chiang C. S., Stalder A., Samimi A., Campbell I. L. Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev. Neurosci. 16:1994;212-221.
84. Choi D. W. Nitric oxide: foe or friend to the injured brain? Proc. natl Acad. Sci. U.S.A. 90:1993;9741-9743.
85. Chung I. Y., Benveniste E. N. Tumor necrosis factor-α production by astrocytes: induction by lipopolysaccharide, IFN-γ and IL-1β J. Immunol. 144:1990;2999-3007.
86. Coceani F., Lees J., Dinatello C. A. Occurrence of interleukin-1 in cerebrospinal fluid of the conscious rat. Brain Res. 446:1988;245-250.
87. Colasanti M., Persichini T., Menegazzi M., Mariotto S., Giordano E., Caldarera C. M., Sogos V., Lauro G. M., Suzuki H. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J. Biol. Chem. 270:1995;26731-26733.
88. Colton C. A., Yao J., Keri J. E., Gilbert D. Regulation of microglial function by interferons. J. Neuroimmunol. 40:1992;89-98.
89. Corbin J. G., Kelly D., Rath E. M., Baerwald K. D., Suzuki K., Popko B. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol. Cell. Neurosci. 7:1996;354-370.
90. Creange A., Barlovatz-Meimon G., Gherardi R. K. Cytokines and peripheral nerve disorders. Eur. Cytokine. Netw. 8:1997;145-151.
91. Cross A. H., Keeling R. M., Goorha S., San M., Rodi C., Wyatt P. S., Manning P. T., Misko T. P. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 71:1996;145-153.
92. D'Souza S. D., Bonetti B., Balasingam V., Cashman N. R., Barker P. A., Troutt A. B., Raine C. S., Antel J. P. Multiple sclerosis: Fas signaling in oligodendrocyte death. J. Exp. Med. 184:1996;2361-2370.
93. Dawson V. L., Dawson T. D., London E. D., Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. natl Acad. Sci. U.S.A. 88:1991;6368-6371.
94. Dawson V. L., Dawson T. M., Bartley D. A., Uhl G. R., Snyder S. H. Mechanisms of nitric oxide mediated neurotoxity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
95. Dawson V. L., Brahmbhatt H. P., Mong J. A., Dawson T. M. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology. 33:1994;1425-1430.
96. Degroote D., Grau G. E., Dehart I., Franchiment P. Stabilisation of functional tumor necrosis factor-α by its soluble TNF receptors. Eur. Cytokine Netw. 4:1993;359-362.
97. Demerlé-Pallardy C., Lonchampt M. O., Chabrier P. E., Braquet P. Nitric oxide synthase induction in glial cells: effect on neuronal survival. Life Sci. 52:1993;1883-1890.
98. Desch C. E., Dobrina A., Aggarwal B. B., Harlan J. M. Tumor necrosis factor alpha exhibits greater proinflammatory activity than lymphotoxin in vitro. Blood. 75:1990;2030-2034.
99. Dewhurst S., Sakai K., Bresser J., Stevenson M., Evingerhodges M. J., Volsky D. J. Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. J. Virol. 61:1987;3774-3782.
100. Di Santo E., Alonzi T., Fattori E., Poli V., Ciliberto G., Sironi M., Gnocchi P., Ricciardi C. P., Ghezzi P. Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production. Brain Res. 740:1996;239-244.
101. Diab A., Zhu J., Xiao B. G., Mustafa M., Link H. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats. J. Neuropathol. Exp. Neurol. 56:1997;641-650.
102. Dickson D. W., Lee S. C., Mattiace L. A., Yen S. H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
103. Dimmeler S., Zeiher A. M. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide Biol. Chem. 4:1997;275-281.
104. Dopp J. M., Mackenzie G. A., Otero G. C., Merrill J. E. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J. Neuroimmunol. 75:1997;104-112.
105. Dreyer E. B., Kaiser P. K., Offermann J. T., Lipton S. A. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science. 248:1990;364-367.
106. Dubois-Dalcq M., Altmeyer R., Chiron M., Wilt S. THIV interactions with cells of the immune system. Curr. Opin. Neurobiol. 5:1995;647-655.
107. Duong T. T., St Louis J., Gilbert J. J., Finkelman F. D., Strejan G. H. Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuorimmunol. 36:1992;105-115.
108. Duong T. T., Finkelman F. D., Singh B., Strejan G. H. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53:1994;101-107.
109. Egwagu C. E., Sztein J., Chan C.-C., Mahdi R., Nussenblatt R. B., Chepellinsky A. B. Gamma-interferon expression disrupts lens and retinal differentiation in transgenic mice. Dev. Biol. 166:1994;557-568.
110. Eneroth A., Andersson T., Olsson T., Orvell C., Norrby E., Kristensson K. Interferon-gamma-like immunoreactivity in sensory neurons may influence the replication of Sendai and mumps viruses. J. Neurosci. Res. 31:1992;487-493.
111. Engelhardt B. The role of α4-integrin in T lymphocyte migration into the inflamed and noninflamed central nervous system. Curr. Top. Microbiol. Immunol. 231:1997;51-64.
112. Engelhardt B., Conley F. C., Kilshaw P. J., Butcher E. C. Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1. Int. Immunol. 7:1995;481-491.
113. Engelmann H., Novick D., Wallach D. Two tumor necrosis factor-binding proteins purified from human urine. J. Biol. Chem. 265:1990;1531-1536.
114. Ensoli F., Ensoli B., Thiele C. J. HIV-1 gene expression and replication in neuronal and glial cell lines with immature phenotype: effects of nerve growth factor. Virology. 200:1994;668-676.
115. Ensoli F., Cafaro A., Fiorelli V., Vannelli B., Ensoli B., Thiele C. J. HIV-1 infection of primary human neuroblasts. Virology. 210:1995;221-225.
116. Eo D. A central role for ciliary neurotropic factor? Proc. natl Acad. Sci. U.S.A. 90:1993;2557-2558.
117. Epstein L. G., Sharer L. R., Joshi V. V., Fojas M. M., Koenigsberger M. R., Oleske J. M. Progressive encephalopathy in children with acquired immunodeficiency syndrome. Ann. Neurol. 17:1985;488-496.
118. Erickson S. L., Sauvage F. J. D., Kikly K., Carver-Moore K., Pitts-Meek S., Gillet N., Sheenan K. C. F., Schreiber R. D., Goeddel D., Moore M. W. Decreased sensitivity to tumor necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature. 372:1994;560-563.
119. Erkman L., Wuarin L., Cadelli D., Kato A. C. Interferon induces astrocyte maturation causing an increase in cholinergic properties of cultured human spinal cord cells. Dev. Biol. 132:1989;375-388.
120. Fabry Z., Waldschmidt M. M., Hendrickson D., Keiner J., Love-Homan L., Takei F., Hart M. N. Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 44. J. Neuroimmunol. 36:1992;1-11.
121. Fabry Z., Fitzsimmons K. M., Herlein J. A., Moninger T. O., Dobbs M. B., Hart M. N. Production of the cytokines interleukin 1 and 6 by murine microvessel endothelium and smooth muscle pericytes. J. Neuroimmunol. 47:1993;23-34.
122. Farrar M. A., Schreiber R. D. The molecular cell biology of interferon-γ and its receptor. A. Rev. Immunol. 11:1993;571-611.
123. Fattori E., Cappelletti M., Costa P., Sellitto C., Cantoni L., Carelli M., Faggioni R., Fantuzzi G., Ghezzi P., Poli V. Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180:1994;1243-1250.
124. Fattori E., Lazzaro D., Musiani P., Modesti A., Alonzi T., Ciliberto G. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur. J. Neurosci. 7:1995;2441-2449.
125. Fauci A. S. Host factors and the pathogenesis of HIV-induced disease: implications for therapy. Science. 384:1996;529-534.
126. Feinstein D. L., Galea E., Reis D. J. Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J. Neurochem. 60:1993;1945-1948.
127. Feinstein D. L., Galea E., Cermak J., Chugh P., Lyandvert L., Reis D. J. Nitric oxide synthase expression in glial cells; suppression by tyrosine kinase inhibitors. J. Neurochem. 62:1994;811-814.
128. Ferber I. A., Brocke S., Taylor-Edward C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C. G. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis. J. Immunol. 156:1996;5-7.
129. Fiebich B. L., Lieb K., Berger M., Bauer J. Stimulation of the sphingomyelin pathway induces interleukin-6 gene expression in human astrocytoma cells. J. Neuroimmunol. 63:1995;207-211.
130. Fiebich B. L., Hull M., Lieb K., Berger M., Bauer J. Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells. J. Neuroxhem. 68:1997;704-709.
131. Fierz W., Endler B., Reske K., Wekerle H., Fontana A. Astrocytes as antigen-presenting cells I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effects on antigen. J. Immunol. 134:1985;3785-3793.
132. Fontana A., Kristensen F., Dubs R., Gemsa D., Weber E. Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J. Immunol. 129:1982;2413-2419.
133. Fox R. J., Levin M. C., Jacobson S. Tumor necrosis factor alpha expression in the spinal cord of human T-cell lymphotropic virus type I associated myelopathy/tropical spastic parasites patients. J. Neurovirol. 2:1996;323-329.
134. Frade J. M., Rodríguez-Tébar A., Barde Y. A. Induction of cell death by engogenous nerve growth through its p75 receptor. Nature. 383:1996;166-168.
135. Franciota D. M., Grimaldi L. M., Martino G. V., Piccolo G., Bergamaschi R., Citterio A., Melzi G. V. Tumor necrosis factor in serum and cerebrospinal fluid of patient with multiple sclerosis. J. Exp. Med. 26:1989;787-789.
136. Frei K., Bodmer S., Schwerdel C., Fontana A. Astrocytes of the brain synthesize interleukin 3-like factor. J. Immunol. 135:1985;4044-4047.
137. Frei K., Siepl C., Groscurth P., Bodmer S., Scheweidel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon gamma treated microglial cells. Eur. J. Immunol. 17:1987;1271-1278.
138. Frei K., Malipiero U. V., Leist T. P., Zinkernagel R. M., Schwab M. E., Fontana A. On the cellular source and function of interleukin. 6 Produced in the central nervous system in viral diseases. Eur. J. Immunol. 19:1989;689-694.
139. Frei K., Frederickson S., Fontana A., Link H. Interleukin-6 is elevated in plasma of multiple sclerosis. J. Neuroimmunol. 31:1991;147-153.
140. Frei K., Piani D., Malipiero U. V., Van Meir E., de Tribolet N., Fontana A. Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. J. Immunol. 148:1992;3140-3146.
141. Frei K., Eugster H. P., Bopst M., Constantinescu C. S., Lavi E., Fontana A. Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1997;2177-2182.
142. Fresno M., Kopf M., Rivas L. Cytokines and infectious diseases. Immunol. Today. 18:1997;56-58.
143. Friedman W. J., Larkfors L., Ayer-LeLièvre C., Ebendal T., Olson L., Persson H. Regulation of beta-nerve growth factor expression by inflammatory mediators in hippocampal cultures. J. Neurosci. Res. 27:1990;374-382.
144. Frohman E. M., Frohman T. C., Dustin M. L., Vayuvegula B., Choi B., Gupta A., van den Noort S., Gupta S. The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-γ, tumor necrosis factor-α, lymphotoxin, and interleukin-1: Relevance to intracerebral antigen presentation. J. Neuroimmunol. 23:1989;117-124.
145. Gadient R. A., Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res. 637:1994;10-14.
146. Gadient R. A., Otten U. H. Interleukin-6 (IL-6) - a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52:1997;379-390.
147. Gadient R. A., Cron K. C., Otten U. Interleukin-1β and tumor necrosis factor-α synergistically stimulated nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci. Lett. 117:1990;335-340.
148. Gadient R. A., Lachmund A., Unsicker K., Otten U. Expression of interleukin-6 (IL-6) and IL-6 receptor mRNAs in rat adrenal medulla. Neurosci. Lett. 194:1995;17-20.
149. Gallo P., Frei K., Rordorf C., Lazdins J., Tavalato B., Fontana A. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23:1989;109-116.
150. Gallo P., Piccinno M. G., Krzalic L., Tavolato B. Tumor necrosis factor alpha (TNF-α) and neurological diseases. Failure in detecting TNF-α in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumors. J. Neuroimmunol. 23:1989;41-44.
151. Gallo P., Piccinno M. G., Krzalic L., Tavolato B., Siden A. A longitudinal study on IL-2, sIL-2, IL-4 and gamma IFN in multiple sclerosis CSF and serum. J. Neurol. Sci. 101:1991;227-232.
152. Garthwaite J., Boulton C. L. Nitric oxide signaling in the central nervous system. A. Rev. Physiol. 57:1995;683-706.
153. Gatanaga T., Hwang C. D., Kohr W., Cappuccini F., Lucci J., Jeffes E. W., Lentz R., Tomich J., Yamamoto R. S., Granger G. A. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc. natl Acad. Sci. U.S.A. 87:1990;8781-8784.
154. Gelbard H. A., Epstein L. G. HIV-1 encephalopathy in children. Curr. Opin. Pediatr. 7:1995;655-662.
155. Gelbard H. A., Nottet H. S., Swindells S., Jett M., Dzenko K. A., Genis P., White R., Wang L., Choi Y. B., Zhang D., Lipton S. A., Tourtellotte W. W., Epstein L. G., Gendelman H. E. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68:1994;4628-4635.
156. Genain C. P., Roberts T., Davis R. L., Nguyen M. -H., Uccelli A., Faulds D., Li Y., Hedgpeth J., Hauser S. L. Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. natl Acad. Sci. U.S.A. 92:1995;3601-3605.
157. Gendron R., Nestel F., Lapp W., Baines M. Expression of tumor necrosis factor α in the developing nervous system. Int. J. Neurosci. 60:1991;129-136.
158. Genis P., Jett M., Bernton E. W., Boyle T., Gelbard H. A., Dzenko K., Keane R. W., Resnick L., Mizrachi Y., Volsky D. J., Epstein L. G., Gendelman H. E. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1992;1703-1718.
159. Giri J. G., Newton R. C., Horuk R. Identification of soluble interleukin-1 binding protein in cell free supernatants. Evidence for soluble interleukin-1 receptor. J. Biol. Chem. 265:1990;17416-17419.
160. Giulian D., Vaca K. Inflammatory glia mediates delayed neuronal damage after ischemia in the CNS. Stroke. 24:1993;I84-I90.
161. Giulian D., Baker T. J., Shih L.-C., Lachman L. B. Interleukin-1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164:1986;594-604.
162. Giulian D., Vaca K., Noonan C. A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science. 250:1990;1593-1596.
163. Glass J. D., Johnson R. T. Human immunodeficiency virus and the brain. A. Rev. Neurosci. 19:1996;1-26.
164. Gold D. P., Schroder K., Powell H. C., Kelly C. J. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 27:1997;2863-2869.
165. Goodman Y., Matson M. P. ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem. 66:1996;869-872.
166. Goodwin J. L., Uemura E., Cunnick J. E. Microglial release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma. Brain Res. 692:1995;207-214.
167. Gottschall P. E., Tatsuno I., Arimura A. Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res. 637:1994;197-203.
168. Grau G. E., Piguet P. -F., Vassalli P., Lambert P. H. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Rev. 112:1989;49-70.
169. Grell M. Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J. Inflamm. 47:1995;8-17.
170. Grimaldi M., Pozzoli G., Navarra P., Preziosi P., Schettini G. Vasoactive intestinal peptide and forskolin stimulate interleukin 6 production by rat cortical astrocytes in culture via a cyclic AMP-dependent, prostaglandin-independent mechanism. J. Neurochem. 63:1994;344-350.
171. Gross S. S., Wolin M. S. Nitric oxide: pathophysiological mechamisms. A. Rev. Physiol. 57:1995;737-769.
172. Gutiérrez E. G., Banks W. A., Kastin A. J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47:1993;169-176.
173. Hama T., Miyamoto M., Tsukui H., Nishio C., Hatanaka H. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci. Lett. 104:1989;340-344.
174. Hama T., Kushima Y., Miyamoto M., Kubota M., Takei N., Hatana H. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postanatal, two-week-old rats in cultures. Neuroscience. 40:1991;445-452.
175. Hampel H., Schoen D., Schwarz M. J., Kotter H. U., Schneider C., Sunderland T., Dukoff R., Levy J., Padberg F., Stubner S., Buch K., Muller N., Moller H. J. Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease. Neurosci. Lett. 228:1997;143-146.
176. Hariri R. J., Chang V. A., Barie P. S., Wang R. S., Sharif S. F., Ghajar J. B. Traumatic injury induces interleukin-6 production by human astrocytes. Brain Res. 636:1994;139-142.
177. Harouse J. M., Kunsch C., Hartle H. T., Laughlin M. A., Hoxie J. A., Wigdahl B., Gonzalez-Scararano F. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J. Virol. 63:1989;2527-2533.
178. Hart M. N., Fabry Z. CNS antigen presentation. Trends Neurosci. 18:1995;475-481.
179. Hauser S. L., Doolittle T. H., Lincoln R., Brown R. H., Dinarello C. A. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of IL-1 and tumor necrosis factor but not interleukin-6. Neurology. 40:1990;1735-1739.
180. Heremans H., Dillen C., Groenen M., Martens E., Billiau A. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma. Eur. J. Immunol. 26:1996;2393-2398.
181. Héry C., Sébire G., Peudenier S., Tardieu M. Adhesion to human neurons and astrocytes to monocytes: the role of interaction of CR3 and ICAM-1 and modulation by cytokines. J. Neuroimmunol. 57:1995;101-109.
182. Hetier E., Ayala J., Bousseau A., Denefle P., Prochiantz A. Amoeboid microglial cells and not astrocytes synthesize TNF-α in swiss mouse brain cell cultures. Eur. J. Neurosci. 2:1990;762-768.
183. Hewett S. J., Corbertt J. A., MacDaniel M. L., Choi D. W. Interferon-gamma and interleukin-1β induce nitric oxide formation from primary mouse astocytes. Neurosci. Lett. 164:1993;229-232.
184. Hewett S. J., Csernansky C. A., Choi D. W. Selective potentiation of NMDA-induced neuronal injury followinginduction of astrocytic iNOS. Neuron. 13:1994;487-494.
185. Heyser C. J., Masliah E., Samimi A., Campbell I. L., Gold L. H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. natl Acad. Sci. U.S.A. 94:1997;1500-1505.
186. Hickey W. F., Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigenin vivo. Science. 239:1988;290-292.
187. Hirota H., Kiyama H., Kishimoto T., Taga T. Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J. Exp. Med. 183:1996;2627-2634.
188. Hirsch M. R., Wietzerbin J., Pierres M., Goridis C. Expression of Ia antigens by cultured astrocytes treated with gamma interferon. Neurosci. Lett. 41:1983;199-203.
189. Hölscher C. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci. 20:1997;298-302.
190. Holt S. J., Grimble R. F., York D. A. Tumor necrosis factor-α and lymphotoxin have opposite effects on sympathetic efferent nerves to brown adipose tissue by direct action in the central nervous system. Brain Res. 497:1989;183-186.
191. Höllberg P., Hafler D. A. Pathogenesis of disease induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328:1993;1173-1182.
192. Hopkins S. J., Rothwell N. J. Cytokines in the nervous system I: expression and receptors. Trends Neurosci. 18:1995;83-88.
193. Horwitz M. S., Evans C. F., McGavern D. B., Rodriguez M., Oldstone M. B. Primary demyelination in transgenic mice expressing interferon-gamma. Nat. Med. 3:1997;1037-1041.
194. Hu J., Ferreira A., van Eldik L. J. S100β induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69:1997;2294-2301.
195. Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C., Moskowitz M. A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
196. Huizinga T. W., Westendorp R. G., Bollen E. L., Keijsers V., Brinkman B. M., Langermans J. A., Breedveld F. C., Verweij C. L., van de Gaer L., Dams L., Crusius J. B., Garcia G. A., van Oosten B., Polman C. H., Pena A. S. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J. Neuroimmunol. 72:1997;149-153.
197. Hull M., Strauss S., Berger M., Volk B., Bauer J. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav. Brain Res. 78:1996;37-41.
198. Hunot S., Boissiere F., Faucheux B., Brugg B., Mouattprigent A., Agid Y., Hirsch E. C. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience. 72:1996;355-363.
199. Hurwith A. A., Lyman W. D., Guida M. P., Calderon T. M., Berman J. W. Tumor necrosis factor α induces adhesion molecule expression on human fetal astrocytes. J. Exp. Med. 176:1992;1631-1636.
200. Hyman B. T., Maezloff K., Wenniger J. J., Dawson T. M., Bredt D. S., Snyder S. H. Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease. Ann. Neurol. 32:1992;818-820.
201. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:1997;132-139.
202. Iadecola C., Zhang F., Casey R., Nagayama M., Ross M. E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17:1997;9157-9164.
203. Ihara S., Iwamatsu A., Fujiyoshi T., Komi A., Yamori T., Fukui Y. Identification of Interleukin-6 as a factor that induces neurite outgrowth by PC12 cells primed with NGF. J. Biochem. 120:1996;865-868.
204. Ii M., Sunamoto M., Ohnishi K., Ichimori Y. beta-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res. 720:1996;93-100.
205. Improta T., Salvatore A. M., DiLuzio A., Romeo G., Coccia E. M., Calissano P. INF-gamma facilitates NGF-induced neuronal differentiation in PC12 cells. Exp. Cell Res. 179:1988;1-9.
206. Interferon-β Multiple Sclerosis Group Interferon beta is effective in relapsing-remitting multiple sclerosis. Neurology. 43:1993;662-667.
207. Jacobson S., Shida H., McFarlin D. E., Fauci A. S., Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 348:1990;245-248.
208. Janssen R. S., Cornblath D. R., Epstein L. G., McArthur J., Price R. W. Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology, AIDS task force. Neurology. 39:1989;119-122.
209. Janzer R. C., Raff M. C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature (London). 325:1987;253-257.
210. Jirik F. R., Podot T. J., Hirano T., Kishimoto T., Loskutoff D. J., Carson D. A., Lotz M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J. Immunol. 142:1989;144-147.
211. Johns L. D., Babcock G., Green D., Freedman M., Sriram S., Ransohoff R. M. Transforming growth factor-β1 differentially regulates proliferation and MHC class II antigen expression in forebrain and brainstem astrocyte primary cultures. Brain Res. 585:1992;229-236.
212. Johnson A. W., Land J. M., Thompson E. J., Bolaños J. P., Clark J. B., Heales S. J. R. Evidence for increased nitric oxide production in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 57:1995;107.
213. Johnson R. W., Arkins S., Dantzer R., Kelley K. W. Hormones, lymphohemopoietic cytokines and the neuroimmune Axis. Comp. Biochem. Physiol. 116A:1997;183-201.
214. Jonakait G. M. Cytokines in neuronal development. Adv. Pharmacol. 17:1997;35-67.
215. Jonakait G. M., Luskin M. B., Wei R., Tian X.-F., Ni L. Conditioned medium from activated microglia promotes cholinergic in the basal forebrain in vitro. Dev. Biol. 177:1996;85-95.
216. Joseph J., Grun J. L., Lublin F. D., Knobler R. L. Interleukin-6 induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (MHV-4 JHM). J. Neuroimmunol. 42:1993;47-52.
217. Katafuchi T., Motomura K., Baba -S., Ota K., Hori T. Differential effects of tumor necrosis factor-alpha and -beta on rat ventromedial hypothalamic neurons in vitro. Am. J. Physiol. 272:1997;R1966-1971.
218. Kawai K., Kobayashi Y., Shiratori M., Sobue G., Tamatani T., Miyasaka M., Yoshikai Y. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis. Cell. Immunol. 171:1996;262-268.
219. Keilhoff G., Seidel B., Noack H., Tischmeyer W., Stanek D., Wolf G. Patterns of nitric oxide synthase at the messenger RNA and protein levels during early rat brain development. Neuroscience. 75:1996;1193-1201.
220. Kent S. J., Karlik S. J., Cannon C., Hines D. K., Yednock T. A., Fritz L. C., Horner H. C. A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J. Neuroimmunol. 58:1995;1-10.
221. Khoury S. J., Hancock W. W., Weiner H. L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1992;1355-1364.
222. Kifle Y., Monnier J., Chesrown S. E., Raizada M. K., Nick H. S. Regulation of the manganese superoxide dismutase and inducible nitric oxide synthase gene in rat neuronal and glial cells. J. Neurochem. 66:1996;2128-2135.
223. Kim J. S. Cytokines and adhesion molecules in stroke and related diseases. J. Neurol. Sci. 137:1996;69-78.
224. Kinouchi K., Brown G., Pasternak G., Donner D. B. Identification and characterization of receptors for tumor necrosis-α in the brain. Biochem. Byophys. Res. Commun. 181:1991;1532-1538.
225. Klein M. A., Moller J. C., Jones L. L., Bluethmann H., Kreutzberg G. W., Raivich G. Impaired neuroglial activation in interleukin-6 deficient mice. Glia. 19:1997;227-233.
226. Klinkert W. E. F., Kojima K., Lesslauer W., Rinner W., Lassmann H., Wekerle H. TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview. J. Neuroimmunol. 72:1997;162-168.
227. Knowles R. G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298:1994;249-259.
228. Kobayashi Y., Kawai K., Honda H., Tomida S., Niimi N., Tamatani T., Miyasaka M., Yoshikai Y. Antibodies against leukocyte functio-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis. Cell. Immunol. 164:1995;295-305.
229. Koenig S., Gendelmam H. E., Orenstein J. M., Canto M. C. D., Pezeshkpour G. H., Yungbluth M., Janotta F., Aksamit A., Martin M. A., Fauci A. S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 233:1986;1089-1093.
230. Koh J. Y., Choi D. W. Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-Diaphorase. J. Neurosci. 8:1988;2153-2163.
231. Koka P., He K., Zack J. A., Kitche S., Peacock W., Fried I., Tran T., Yashar S. S., Merrill J. E. Human immunodeficiency virus 1 envelope proteins induce interleuking 1, tumor necrosis factor α, and nitric oxide in glial cultures derived from fetal, neonatal and adult human brain. J. Exp. Med. 182:1995;941-952.
232. Köller H., Siebler M., Hartung H. P. Immunologically induced electrophysiological dysfunction: implications for inflammatory diseases of the CNS and PNS. Prog. Neurobiol. 52:1997;1-26.
233. Koprowski H., Zheng Y. M., Heber-Katz E., Fraser N., Rorke L., Fu Z. F., Hanlon C., Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. natl Acad. Sci. U.S.A. 90:1993;3024-3027.
234. Kòrner H., Goodsall A. L., Lemckert F. A., Scallon B. J., Ghrayeb J., Ford A. L., Sedgwick J. D. Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis. Proc. natl Acad. Sci. U.S.A. 92:1995;11066-11070.
235. Körner H., Riminton D. S., Strickland D. H., Lemckert F. A., Pollard J. D., Sedwick J. D. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1997;1585-1590.
236. Kossmann T., Hans V., Imhof H. G., Trentz O., Morganti K. M. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 713:1996;143-152.
237. Krakowski M., Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1996;1641-1646.
238. Kriegler M., Perez C., DeFay K., Albert I., Lu S. D. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell. 53:1988;45-53.
239. Kröncke K. D., Fehsel K., Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection. How, why, when, and where? Nitric Oxide Biol. Chem. 1:1997;107-120.
240. Kubes, P. (Ed.) (1995). Nitric Oxide: A Modulator of Cell-cell Interactions in the Microcirculation. R. G. Landes Co. Austin, Texas.
241. Kuchroo V. K., Martin C. A., Greer J. M., Ju S. T., Sobel R. A., Dorf M. E. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:1993;4371.
242. Kure K., Llena J. F., Lyman W. D., Soeiro R., Weidenheim K. M., Hirano A., Dickson D. W. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum. Pathol. 22:1991;700-710.
243. Kuroda Y., Matsui M. Cerebrospinal fluid interferon-gamma is increased in HTLV-I associated myelopathy. J. Neuroimmunol. 42:1993;223-226.
244. Kushima Y., Hatanaka H. Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord. Neurosci. Lett. 143:1992;110-114.
245. Kushima Y., Hama T., Hatanaka H. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neurosci. Res. 13:1992;267-280.
246. Lachman L. B., Brown D. C., Dinarello C. A. Growth promoting effect of recombinant interleukin-1 and tumor necrosis factor for a human astrocytoma cell line. J. Immunol. 138:1987;2913-2916.
247. Lafortune L., Nalbantoglu J., Antel J. P. Expression of tumor necrosis factor alpha (TNF alpha) and interleukin 6 (IL-6) mRNA in adult human astrocytes: comparison with adult microglia and fetal astrocytes. J. Neuropathol. Exp. Neurol. 55:1996;515-521.
248. Lander H. M., Sehajpal P., Levine D. M., Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1993;1509-1516.
249. Lavi E., Suzumura A., Murasko D. M., Murray E. M., Silberberg D. H., Weiss S. R. Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes. J. Neuroimmunol. 18:1988;245-253.
250. Lechan R. M., Toni R., Clark B. D., Cannon J. G., Shaw A. R., Dinarello C. A., Reichlin S. Immunoreactive interleukin-1β localization in the rat forebrain. Brain Res. 514:1990;135-140.
251. Lee S. C., Dickson D. W., Liu W., Brosnan C. F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon γ J. Neuroimmunol. 46:1993;19-24.
252. Lee S. C., Liu W., Dickson D. W., Brosnan C. F., Berman J. W. Cytokine production by human fetal microglia and astrocytes: differential induction by lipopolysaccharide and IL-1β J. Immunol. 150:1993;2659-2667.
253. Lee S. C., Dickson D. W., Brosnan C. F. Interleukin-1, nitric oxide and reactive astrocytes. Brain Behav. Immun. 9:1995;345-354.
254. Leist T. P., Frei K., Kam-Hansen S., Zinkernagal R. M., Fontana A. Tumor necrosis factor in cerebrospinal fluid during bacterial but not viral meningitis. J. Exp. Med. 167:1988;1743-1748.
255. Li X. L., Moudgil T., Vinters H. V., Ho D. D. CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. J. Virol. 64:1990;1383-1387.
256. Lieberman A. P., Pitha P. M., Shin H. S., Shin M. L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. natl Acad. Sci. U.S.A. 86:1989;6348-6352.
257. Lindholm D., Heumann R., Meyer M., Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 330:1987;658-659.
258. Link H., Mauerhoff T., Pujol-Borrel R., Mirakin R., Bottazzo G. F. Differential expression and regulation of major histocompatibility complex (MHC) products in neural and glial cells of the human-fetal brain. J. Neuroimmunol. 18:1988;271-289.
259. Link H., Sun J. B., Wang Z. Y., Xu Z., Löve A., Fedrikson S., Olsson T. Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 78:1992;63-73.
260. Link J., Söderström M., Ljungdah Å., Höjeberg B., Olsson T., Xu Z., Fredrikson S., Wang Z.-Y. Organ-specific autoantigens induce interferon-γ and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Neurology. 44:1994;728-734.
261. Lipton S. A. Janus faces of NF-kappa B: neurodestruction versus neuroprotection. Nat. Med. 3:1997;20-22.
262. Liu J., Zhao M. L., Brosnan C. F., Lee S. C. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1beta and IL-1 receptorantagonist. J. Immunol. 157:1996;3569-3576.
263. Lucas R., Juillard P., Decoster E., Redard M., Burger D., Donati Y., Giroud C., Monso-Hinard C., De Kesel T., Buurman W. A., Moore M. W., Dayer J. M., Fiers W., Bluethmann H., Grau G. E. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane bound TNF in experimental cerebral malaria. Eur. J. Immunol. 27:1997;1719-1725.
264. Luheshi G. N., Gay J., Rothwell N. J. Circulating IL-6 is transported into the brain via a saturable transport mechanism in the rat. Br. J. Pharmacol. 111:1994;146P.
265. MacMicking J. D., Xie Q. W., Nathan C. Nitric oxide and macrophage function. A. Rev. Immunol. 15:1997;323-350.
266. Magnuson D. S., Knudsen B. E., Geiger J. D., Brownstone R. M., Nath A. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37:1995;373-380.
267. Magnusson S., Alm P., Kanje M. Inducible nitric oxide synthase increases in regenerating rat ganglia. Neuroreport. 7:1996;2046-2050.
268. Maimone D., Gregory S., Arnason B. G. W., Reder A. T. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J. Neuroimmunol. 32:1991;67-74.
269. Maimone D., Cioni C., Rosa S., Macchia G., Aloisi F., Annunziata P. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1β and TNFα J. Neuroimmunol. 47:1993;73-82.
270. Maimone D., Guazzi G. C., Annunziata P. IL-6 detection in multiple sclerosis brain. J. Neurol. Sci. 146:1997;59-65.
271. Malipiero U. V., Frei K., Fontana A. Productionof hemopoietic colony-stimulating factors by astrocytes. J. Immunol. 144:1990;3816-3821.
272. Marino M. W., Dunn A., Grail D., Inglese M., Noguchi Y., Richards E., Jungbluth A., Wada H., Moore M., Williamson B., Basu S., Old L. J. Characterization of tumor necrosis factor deficient mice. Proc. natl Acad. Sci. U.S.A. 94:1997;8093-8098.
273. Marz P., Gadient R. A., Otten U. Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-α). Brain Res. 706:1996;71-79.
274. Masliah E., Ge N., Mucke L. Pathogenesis of HIV-1 associated neurodegeneration. Crit. Rev. Neurobiol. 10:1996;57-67.
275. Massa P. T., Schmipl A., Wecker E., ter Meulen V. Tumor necrosis factor amplifies virus-mediated Ia induction on astrocytes. Proc. natl Acad. Sci. U.S.A. 84:1987;7242-7245.
276. Mattson M. P. Excitatory amino acids, growth factors, and calcium: a teeter-totter model for neural plasticity anddegeneration. Adv. Exp. Med. Biol. 268:1990;211-220.
277. Mattson M. P., Barger S. W., Furukawa K., Bruce A. J., Wyss-Coray T., Mark R. J., Mucke L. Cellular signalling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease. Brain Res. Rev. 23:1997;47-61.
278. Matusevicius D., Navikas V., Soderstrom M., Xiao B. G., Haglund M., Fredrikson S., Link H. Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells. J. Neuroimmunol. 66:1996;115-123.
279. May M. J., Ghosh S. Signal transduction through NF-κB. Immunol. Today. 19:1998;80-88.
280. McCarron R. M., Wang L., Racke M. K., McFarlin D. E., Spatz M. Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43:1993;23-30.
281. McEwen B. S., Biro C. A., Brunson K. W., Bulloch K., Chambers W. H., Dhabhar F. S., Goldfarb R. H., Kitso R. P., Miller A. H., Spemer R. L., Weiss J. M. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Rev. 23:1997;76-133.
282. Meda L., Cassatella M. A., Szendrei G. I., Otvos L. Jr., Baron P., Villaba M., Ferrari D., Rossi F. Activation of microglial cells by β-amyloid protein and interferon-γ Nature. 374:1995;647-650.
283. Mehler M. F., Kessler J. A. Hematopoietic cytokines in neural development. Trends Neurosci. 20:1997;357-365.
284. Méndez E., Kawanishi T., Clemens K., Siomi H., Soldan S. S., Calabres P., Brady J., Jacobson S. Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic cells. J. Virol. 71:1997;9143-9149.
285. Merril J. E. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathologic. Dev. Neurosci. 14:1992;1-10.
286. Merrill J. E., Benveniste E. N. Cytokines in inflammatory brain lessions: helpful and harmful. Trends Neurosci. 19:1996;331-338.
287. Merrill J. E., Ignarro L. J., Sherman M. P., Melinek J., Lane T. E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
288. Milstien S., Sakai N., Brew B. J., Krieger C., Vickers J. H., Saito K., Heyes M. P. Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases. J. Neurochem. 63:1994;1178-1180.
289. Minc-Golomb D., Yadid G., Tsarfaty I., Resau J. H., Schwartz I. P. In vivo expression of inducible nitric oxide synthase in cerebellar neurons. J. Neurochem. 66:1996;1504-1509.
290. Mizrachi Y., Rodriguez I., Sweetnam P. M., Rubinstein A., Volsky D. J. HIV type 1 infection of human cortical neuronal cells: enhancement by select neuronal growth factors. AIDS Res. Hum. Retroviruses. 10:1994;1593-1596.
291. Mizuno T., Sawada M., Suzumura A., Marunouchi T. Expression of cytokines during glial differentiation. Brain Res. 656:1994;141-146.
292. Mollace V., Colasante M., Persichini T., Bagetta G., Lauro G. M., Nistico G. HIV gp120 glycoprotein stimulates the inducible isoform of NO synthase in human cultured astrocytoma cells. Biochem. Biophys. Res. Commun. 194:1993;439-445.
293. Morganti-Kossmann M. C., Kossmann T., Brandes M. E., Mergenhagen S. E., Wahl S. M. Autocrine and paracrine regulation of astrocyte function by transforming growth factor β J. Neuroimmunol. 19:1992;163-174.
294. Morrissey S. P., Deichmann R., Syha J., Simonis C., Zettl U., Archelos J. J., Jung S., Stodal H., Lassmann H., Toyka K. V., Haase A., Hartung H. P. Partial inhibition of AT-EAE by an antibody to ICAM-1: clinico-histological and MRI studies. J. Neuroimmunol. 69:1996;85-93.
295. Moses A. V., Bloom F. E., Pauza C. D., Nelson J. A. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc. natl Acad. Sci. U.S.A. 90:1993;10474-10478.
296. Mossman T. R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
297. Mufson E. J., Brandabur M. M. Sparing of NADPH-diaphorase striatal neurons in Parkinson's and Alzheimer's diseases. Neuro. Report. 5:1994;705-708.
298. Muñoz-Fernández M. A., Fresno M. Involvement of nitric oxide on the cytokine induced growth of glial cell. Biochem. Biophys. Res. Commun. 194:1993;319-325.
299. Muñoz-Fernández M. A., Armas-Portela R., Díaz-Nido J., Alonso J. L., Fresno M., Avila J. Differential effect of tumor necrosis factor on the growth and differentiation of neuroblastoma and glioma cells. Exp. Cell. Res. 194:1991;161-164.
300. Muñoz-Fernández M. A., Cano E., O'Donnell C. A., Doyle J., Liew F. Y., Fresno M. TNF-α, IFN-γ and IL-6 but not TNF-β induce differentiation of neuroblastoma cells: the role of nitric oxide. J. Neurochem. 64:1994;1330-1336.
301. Muñoz-Fernández M. A., Obregón E., Navarro J., Börner C., Gurbindo M. D., Sampelayo T. H., Fernández-Cruz E. Relationship among virological, immunological, and clinical parameters in infants with vertically acquired human immunodeficiency virus (HIV-1) infection. Pediatric Res. 40:1996;597-602.
302. Muñoz-Fernández M. A., Navarro J., Garcia A., Punzón C., Fernández-Cruz E., Fresno M. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kB activation. J. Allergy Clin. Immunol. 100:1997;838-845.
303. Nath A., Psooy K., Martin C., Knudsen B., Magnuson D. S., Haughey N., Geiger J. D. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70:1996;1475-1480.
304. Nathan C., Xie Q.-W. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:1994;915-918.
305. Navikas V., Link H. Review: cytokines and the pathogenesis of multple sclerosis. J. Neruosci. Res. 45:1996;322-333.
306. Neumann H., Boucraut J., Hahnel C., Misgeld T., Wekerle H. Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur. J. Neurosci. 8:1996;2582-2590.
307. Neumann H., Schmidt H., Cavalie A., Jenne D., Wekerle I. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-γ and tumor necrosis factor (TNF)-α J. Exp. Med. 185:1997;305-316.
308. Nikcevich K. M., Gordon K. B., Tan L., Hurst S. D., Kroepfl J. F., Gardinier M., Barrett T. A., Miller S. D. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J. Immunol. 158:1997;614-621.
309. Noronha A., Toscas A., Jensen M. A. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. J. Neuroimmunol. 46:1993;145-153.
310. Norris J. G., Tang L. P., Sparacio S. M., Benveniste E. N. Signal transduction pathways mediating astrocyte IL-6 induction by IL-1β and tumor necrosis factor-α J. Immunol. 152:1994;841-850.
311. Nottet H. S. L. M., Gendelman H. E. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol. Today. 16:1995;441-448.
312. Nottet H. S. L. M., Persidsky Y., Sasseville V. G., Nukuna A. A., Bock P., Zhai Q. H., Sharer L. R., McComb R., Swindells S., Soderland C., Gendelman H. E. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 156:1996;1284-1295.
313. Novick D., Engelmann H., Wallach D., Leitner O., Revel M., Rubenstein M. Purification of soluble cytokine receptors from normal human urine ligand affinity and immunoaffinity chromatography. J. Chomatrogr. 510:1990;331-337.
314. Nowicki J. P., Duval D., Poiguet H., Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmacol. 204:1991;339-340.
315. Nuovo G. J., Alfieri M. L. AIDS Dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Molecular Med. 2:1996;358-366.
316. Nuovo G. J., Gallery F., MacConnell P., Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am. J. Pathol. 144:1994;659-666.
317. O'Neill L. A., Kaltschmidt C. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:1997;252-258.
318. Obregón E., Börner C., Navarro J., Gurbindo M. D., Férnandez-Cruz E., Muñoz-Fernández M. A. Elevated levels of circulating intercellular adhesion molecule 1 and tumor necrosis factor α in the serum of children vertically infected with HIV-1. Pediatric AIDS and HIV Infection. 7:1996;413-417.
319. Obregon E., Punzon M. C., Gonzalez N. J., Fernández-Cruz E., Fresno M., Muñoz-Fernández M. A. Induction of adhesion/differentiation of human neuroblastoma cells by tumour necrosis factor-alpha requires the expression of an inducible nitric oxide synthase. Eur. J. Neurosci. 9:1997;1184-1193.
320. Obregon, E., Punzon, M. C., Fernández-Cruz, E., Fresno, M. and Muñoz-Fernández, M. A. (1988) HIV-1 infection of neuroblastoma cells induces their differentiation through a TNF and nitric oxide mediated mechanism. J. Neurosci.
321. Ogura T., Esumi H. Nitric oxide synthase expression in human neuroblastoma cell line induced by cytokines. Neuroreport. 7:1996;853-856.
322. Oh Y., O'Malley K. IL-6 increases choline acetyltransferase but not neuropeptide transcripts in sympathetic neurons. Neuroreport (Engl.). 4:1994;937-940.
323. Okuda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakoda S. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:1995;103-112.
324. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 73:1997;107-116.
325. Olsson T., Wang W. Z., Höjeberg B., Kostulas V., Yiang Y. P., Andersson G., Ekre H. P., Link H. Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of interferon-gamma. J. Clin. Invest. 86:1990;981-985.
326. Olsson T., Kelic S., Edlund C., Bakhiet M., Höjeberg B., van der Meide P. H., Ljungdahl A., Kristensson K. Neuronal interferon-gamma immunoreactive molecule: bioactivities and purification. Eur. J. Immunol. 24:1994;308-314.
327. Opp M. R., Obal F., Cody A. B., Johansen L., Krueger J. M. Interleukin-6 is pyrogenic but not somnogenic. Physiol. Behav. 45:1989;1069-1072.
328. Otero G. C., Merrill J. E. Cytokine receptors on glial cells. Glia. 11:1994;117-128.
329. Pan W., Banks W. A., Kastin A. J. Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury. Exp. Neurol. 146:1997;367-373.
330. Panek R. B., Lee Y. J., Lindstrom-Itoh Y., Ting J. P., Benveniste E. N. Characterization of astrocyte nuclear proteins involved in IFN-γ and TNF-α mediated class II MHC gene expression. J. Immunol. 153:1994;4555-4564.
331. Panitch H. S., Hirsch L., Schindler J., Johnson K. P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology. 37:1987;1097-1102.
332. Patterson P. The emerging neuropoietic cytokine family: first CDF/LIF, CNTF and IL-6; next ONC, MGF, GCSF? Curr. Opin. Neurobiol. 2:1992;94-97.
333. Peng H. B., Libby P., Liao J. K. Induction and stabilization of I kappa B
334. Perry V. H., Bell M. D., Brown H. C., Matyszak M. K. Inflammation in the nervous system. Curr. Opin. Neurobiol. 5:1995;636-641.
335. Peter J. B., Boctor F. N., Tourgellotte W. W. Serum and CSF levels of IL-2, sIL-2R, TNF-α, and IL-1β in chronic progressive multiple sclerosis: expected lack of clinical utility. Neurology. 41:1991;121-123.
336. Peuchen S., Bolaños J. P., Heales S. J. R., Almeida A., Duche M. R., Clark J. B. Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system. Prog. Neurobiol. 52:1997;261-281.
337. Peunova N., Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature. 375:1995;68-73.
338. Peunova N., Kuzin B., Roberts I., O'Kane C., Enikolopov G. Nitric oxide, cell multiplication and cell survival. Cold Spring Harb. Symp. Quant. Biol. 56:1996;417-426.
339. Pfeffer K., Matsuyama T., Kunding T. M., Wakehamn A., Kishiara K., Shahinian A., Wiegeman K., Ohasi P. S., Kröncke M., Mak T. W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock yet succumb to L. monocyogenes infection. Cell. 73:1993;457-467.
340. c in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J. Immunol. 152:1994;3578-3585.
341. Pietraforte D., Tritarelli E., Testa U., Minetti M. gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J. Leukoc. Biol. 55:1994;175-182.
342. Pimentel-Muiños F. X., Muñoz-Fernández M. A., Fresno M. Control of T lymphocyte activation and interleukin 2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152:1994;5714-5722.
343. Plioplys A. V. Expression of the 210 kDa neurofilament subunit in cultured central nervous system from normal and trisomy 15 mice: regulation by interferon. J. Neurol. Sci. 85:1988;209-222.
344. Pober J. S., Gimbrone M. A., Lapierre D. L., Mendrik D. L., Fiers W., Rothlein R., Springer T. A. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1986;1893-1896.
345. Pohlman T. H., Stanness K. A., Beatty P. G., Ochs H. D., Harlan J. M. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherance by a CD18-dependent mechanism. J. Immunol. 136:1986;4548-4553.
346. Poluha W., Schonhoff C. M., Harrington K. S., Lachyankar M. B., Crosbie N. E., Bulseco D. A., Ross A. H. A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cells. J. Biol. Chem. 272:1997;24002-24007.
347. Ponzoni M., Casalaro A., Lanciotti M., Giuseppe P., Cornaglia-Ferraris P. The combination of γ-interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells. Cancer Res. 52:1992;931-939.
348. Popko B., Corbin J. G., Baerwald K. D., Dupree J., Garcia A. M. The effects of interferon-gamma on the central nervous system. Mol. Neurobiol. 14:1997;19-35.
349. Pousset F. Developmental expression of cytokine genes in the cortex and hippocampus of the rat central nervous system. Dev. Brain Res. 81:1994;143-146.
350. Power C., Kong P. A., Crawford T. O., Wesselingh S., Glass J. D., McArthur J. C., Trapp B. D. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann. Neurol. 34:1993;339-350.
351. Power C., McArthur J. C., Johnson R. T., Griffin D. E., Glass J. D., Dewey R., Chesebro B. Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence. Curr. Top. Microbiol. Immunol. 202:1995;89-104.
352. Price R. W. AIDS dementia complex: a complex, slow virus "model" of acquired genetic neurodegenerative disease. Cold Spring Harbor Symp. Quant. Biol. 61:1996;759-770.
353. Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. natl Acad. Sci. U.S.A. 92:1995;11294-11298.
354. Probert L., Akassoglou K., Kassiotis M., Pasparakis M., Alexopoulou L., Kollias G. TNF-α transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72:1997;137-141.
355. Raine C. S. Multiple sclerosis: TNF revisited, with promise. Nature. 1:1995;211-214.
356. Raine C. S. The Norton Lecture: a review of the oligondendrocyte in the multiple sclerosis lesion. J. Neuroimmunol. 77:1997;135-152.
357. Raine C. S., Lee S. C., Scheinberg L. C., Duijvestijn A. M., Cross A. H. Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis. Clin. Immunol. Immunopathol. 57:1990;173-187.
358. Rieckmann P., Altenhofen B., Riegel A., Baudewig J., Felgenhauer K. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis. Ann. Neurol. 41:1997;326-333.
359. Righi M., Mori L., De Libero G., Sironi M., Biondi A., Mantovani A., Donini S. D., Ricciardi-Castagnoli P. Monokine production by microglial cell clones. Eur. J. Immunol. 19:1989;1443-1448.
360. Ringheim G. E., Burgher K. L., Heroux J. A. Interleukin-6 mRNA expression by cortical neurones in culture; evidence for neuronal sources of interleukin-6 in the brain. J. Neuroimmunol. 63:1995;113-123.
361. Robbins D. S., Shiraze Y., Drysdale B. E., Lieberman A., Shin H. S., Shin M. L. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol. 139:1987;2593-2597.
362. Rossi F., Bianchini E. Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes. Biochem. Biophys. Res. Commun. 225:1996;474-478.
363. Rothe M., Pan M. G., Henzel W. J., Ayres T. M., Goeddel D. V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83:1995;1243-1252.
364. Rothwell N. J., Hopkins S. J. Cytokines and the nervous system II: actions and mechanisms. Trends Neurosci. 18:1995;130-136.
365. Rothwell N. J., Lukeshi G., Toulmond S. Cytokines and their receptors in the central nervous system: physiology, pharmacology and pathology. Pharmacol. Ther. 69:1996;85-95.
366. Royston M. C., Rothwell N. J., Robets G. W. Alzheimer's disease from molecular biology to treatment. Trends Pharmacol. Sci. 13:1992;131-133.
367. Ruddle N. H., Bergman C. M., McGrath K. M., Lingenheld E. G., Grunnet M. L., Padula S. J., Clark R. B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 173:1990;1193-1200.
368. Ruuls S. R., de L. M., Weber K. S., Botman C. A., Groenestein R. J., Dijkstra C. D., Olsson T., van der Meide P. The length of treatment determines whether IFN-beta prevents or aggravates experimental autoimmune encephalomyelitis in Lewis rats. J. Immunol. 157:1996;5721-5731.
369. Sabatier J. M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B., Bahraqui E. Evidence for neurotoxic activity of Tat from human immunodeficiency virus type 1. J. Virol. 65:1991;961-967.
370. Sagoh M., Yoshida K., Wakamoto H., Yazaki T., Otani M., Toya S., Gage F. H. Activation of non-NGF type cholinergic neurotrophic activity of astrocytes by cytokines. Soc. Neurosci. Abstr. 19:1993;240-247.
371. Saito Y., Sharer L. R., Epstein L. G., Michaels J., Mintz M., Louder M., Golding K., Cvetkovich T. A., Blumberg B. M. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology. 44:1994;474-481.
372. Sato I., Himi T., Murota S. Lipopolysaccharide-induced nitric oxide synthase activity in cultured cerebellar granule neurons. Neurosci. Lett. 205:1996;45-48.
373. Satoh T., Nakamura S., Taga T., Matsuda T., Hirano T., Kishimoto T., Kaziro Y. Induction of neuronal differentiation in PC 12 cells by B-cell stimulatory factor 2/interleukin 6. Mol. Cell. Biol. 8:1988;3546-3549.
374. Satoh J., Kastrukoff L. F., Kim S. U. Cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) in cultured human oligodendrocytes and astrocytes. J. Neuropathol. Exp. Neurol. 50:1991;215-226.
375. Satoh J., Kim S. U., Kastrukoff L. F., Takei F. Expression and induction of intracellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes. J. Neurosci. Res. 29:1991;1-12.
376. Sawada M., Kondo N., Suzumura A., Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491:1989;394-397.
377. Schmidt B., Stoll G., Toyka K. V., Hartung H. P. Rat astrocytes express interferon-gamma immunoreactivity in normal optic nerve and after nerve transection. Brain Res. 515:1990;347-350.
378. Schöbitz B., Voorhuis D. A. M., De Kloet E. R. Localization of interleukin-6 mRNA and interleukin-6 receptor mRNA in rat brain. Neurosci. Lett. 136:1992;189-192.
379. Sébire G., Emilie D., Wallon C., Hery C., Devergne O., Delfraissy J. F., Galanaud P., Tardieu M. In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. J. Immunol. 150:1993;1517-1523.
380. Selmaj K. W., Raine C. S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;339-346.
381. Selmaj K. W., Farooq M., Norton W. T., Raine C. S., Borsnan C. F. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J. Immunol. 144:1990;129-135.
382. Selmaj K. W., Raine C. S., Farooq M., Norton W. T., Brosnan C. F. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. 147:1991;1522-1529.
383. Selmaj K. W., Raine C. S., Cannella B., Brosnan C. F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87:1991;949-954.
384. Selmaj K. W., Papierz W., Glabinski A., Kohno T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56:1995;135-141.
385. Sharief M. K., Hentges R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325:1991;467-472.
386. Shen Y., Li R., Shiosaki K. Inhibition of p75 tumor necrosis factor receptor by antisense oligonucleotides increases hypoxic injury and beta-amyloid toxicity in human neuronal cell line. J. Biol. Chem. 272:1997;3550-3553.
387. Sheng J. G., Mrak R. E., Griffin W. S. T. S100β protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39:1994;398-404.
388. Shrikant P., Chung I. Y., Ballestas M., Benveniste E. N. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-γ in astrocytes. J. Neuroimmunol. 51:1994;209-220.
389. Shrikant P., Weber E., Jilling T., Benveniste E. N. ICAM-1 gene expression by glial cells: differential mechanisms of inhibition by interleukin-10 and interleukin-6. J. Immunol. 155:1995;1489-1501.
390. Simmons M. L., Murphy S. Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur. J. Neurosci. 5:1993;825-831.
391. Skias D. D., Kim D. K., Reder A. T., Antel J. P., Lancki D. W., Fitch F. W. Susceptibility of astrocytes to class I MHC antigen-specific cytotoxicity. J. Immunol. 138:1987;3254-3258.
392. Sobel R. A., Mitchell M. E., Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 136:1990;1309-1316.
393. Sommer N., Loschmann P. A., Northoff G. H., Weller M., Steinbrecher A., Steinbach J. P., Lichtenfels R., Meyermann R., Riethmuller A., Fontana A., Dichgans J., Martin R. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med. 1:1995;244-248.
394. Sparacio S. M., Zhang Y., Vilcek J., Benveniste E. N. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of NF-kappa β-like nuclear protein. J. Neuroimmunol. 39:1992;231-242.
395. Spranger M., Lindholm D., Bandtlow C., Heumann R., Gnahn H., Naher-Noe M., Thoenen H. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2:1990;69-76.
396. Springer T. A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. A. Rev. Physiol. 57:1995;827-872.
397. St Pierre B. A., Granger D. A., Wong J. E., Merril J. E. A study on tumor necrosis factor, tumor necrosis factor receptors and nitric oxide in human fetal glial cultures. Adv. Pharmacol. 34:1995;415-438.
398. Steffen B. J., Butcher E. C., Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am. J. Pathol. 145:1994;189-201.
399. Steinman L. Some misconceptions about understanding autoimmunity through experiements with knockouts. J. Exp. Med. 185:1997;2039-2041.
400. Stemple D. L., Mahanthappa N. Neural stem cells are blasting off. Neuron. 18:1997;1-4.
401. Stins M. F., Gilles F., Kim K. S. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J. Neuroimmunol. 76:1997;81-90.
402. Suen W. E., Bergman C. M., Hjelmstrom P., Ruddle N. H. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186:1997;1233-1240.
403. Sun J. B., Link H., Xiao B. G., Diener P., Andersson G., Ekre H. P., Linington C., Olsson T. T and B cell responses to myelinoligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146:1991;1490-1495.
404. Sun J. B., Olsson T., Wang W. Z., Xiao B.-G., Kostulas V., Fredrikson S., Ekre H.-P., Link H. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21:1991;1461-1468.
405. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. A. Rev. Immunol. 15:1997;797-819.
406. Takahashi K., Wesselingh S. L., Griffin D. E., McArthur J. C., Johnson R. T., Glass J. D. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 39:1996;705-711.
407. Taupin V., Renno T., Bourbonniere L., Peterson A. C., Rodriguez M., Owens T. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice prodiving tumor necrosis factor-α in the central nervous system. Eur. J. Immunol. 27:1997;905-913.
408. Thippeswamy T., Morris R. Nerve growth factor inhibits the expression of nitric oxide synthase in neurones in dissociated cultures of rat dorsal root ganglia. Neurosci. Lett. 230:1997;9-12.
409. Tilg H., Trehu E., Atkins M. B., Dinarello C. A., Mier J. W. IL-6 as antiinflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 83:1995;113-118.
410. Tilg H., Dinarello C. A., Mier J. W. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol. Today. 18:1997;428-432.
411. Ting J. P. Y., Shigekawa B. L., Linthicum D. S., Weiner L. P., Frelinger J. A. Expression and synthesis of murine immune response-associated (Ia) antigens by brain cells. Proc. natl Acad. Sci. U.S.A. 78:1981;3170-3174.
412. Togashi H., Sasaki M., Frohman E., Taira E., Ratan R. R., Dawson T. M., Dawson V. L. Neuronal (type I) nitric oxide synthase regulates nuclear factor κB activity and immunologic (type II) nitric oxide synthase expression. Proc. natl Acad. Sci. U.S.A. 94:1997;2676-2680.
413. Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham C. R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 367:1994;188-193.
414. Tornatore C., Chandra R., Berger J. R., Major E. O. HIV-infection of subcortical astrocytes in the pediatric central nervous system. Neurology. 44:1994;481-487.
415. Tornatore C., Meyers K., Atwood W., Conant K., Major E. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J. Virol. 68:1994;93-102.
416. Torres C., Aranguez I., Rubio N. Expression of interferon-gamma receptors on murine oligodendrocytes and its regulation by cytokines and mitogens. Immunology. 86:1995;250-255.
417. Toulmond S., Vige X., Fage D., Benavides J. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci. Lett. 144:1992;49-52.
418. Tran E. H., Hardin P. H., Verge G., Owens T. Astrocytes and microglia express inducible nitric oxidesynthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 74:1997;121-129.
419. Traugott U., Lebon P. Multiple sclerosis: involvement of interferons in lesion pathogenesis. Ann. Neurol. 24:1988;243-251.
420. Tsukada N., Miagi K., Matsuda M., Yanagisawa N., Yone K. Tumor necrosis factor and interleukin-1 in CSF and sera of patients with multiple sclerosis. J. Neuroimmunol. 102:1991;230-234.
421. Turnley A. M., Miller J. F., Barlett P. F. Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-gamma and TNF-alpha. Neurosci. Lett. 123:1991;45-48.
422. Tweardy D. J., Glazer E. W., Mott P. L., Anderson L. Modulation by tumor necrosis factor-α of human astroglial cell production of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF). J. Neuroimmunol. 32:1991;269-278.
423. Tyor W. R., Glass J. D., Griffin J. W., Becker P. S., McArthur J. C., Bezman L., Griffin D. E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:1992;349-360.
424. Vallieres L., Rivest S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta. J. Neurochem. 69:1997;1668-1683.
425. Vandenabeele P., Fiers W. Is amyloidogenesis during Alzheimer's disease due to an IL-1/IL-6 mediated acute phase response in the brain? Immunol. Today. 12:1991;207-219.
426. Vandevyver C., Raus P., Stinissen P., Philippaerts L., Cassiman J. J., Raus J. Polymorphism of the tumour necrosis factor beta gene in multiple sclerosis and rheumatoid arthritis. Eur. J. Immunogenet. 21:1994;377-382.
427. Vartanian T., Li Y., Zhao M., Stefansson K. Interferon-γ-induced ologodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1:1995;732-742.
428. Vidovic M., Sparacion S. M., Elovitz M., Benveniste E. N. Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-gamma and tumor necrosis factor-alpha. J. Neuroimmunol. 30:1990;189-200.
429. Villarroya H., Marie Y., Ouallet J. C., Le-Saux F., Tchelingerian J. L., Baumann N. Expression of TNF alpha in central neurons of Lewis rat spinal cord after EAE induction. J. Neurosci. Res. 49:1997;592-599.
430. Vodovotz Y., Lucia M. S., Flanders K. C., Chesler L., Xie Q. W., Smith T. W., Weidner J., Mumford R., Webber R., Nathan C., Roberts A. B., Lippa C. F., Sporn M. B. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184:1996;1425-1433.
431. Voorthuis J. A. C., Uitdehaag B. M. J., De Groot C. J. A., Goede P. H., Van der Meide P. H., Dijkstra C. D. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in rats. Clin. Exp. Immunol. 81:1990;183-188.
432. Waage A., Halstensen A., Shalaby R., Brandtzaeg P., Kierulf P., Espevik T. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J. Exp. Med. 170:1989;1859-1867.
433. Wagner J. A. Is IL-6 both a cytokine and a neurotrophic factor? J. Exp. Med. 183:1996;2417-2419.
434. Wallach D. TNF: a decade of accumulated knowledge and emerging answers. Eur. Cytokine Netw. 7:1996;713-724.
435. Weeks B. S., Lieberman D. M., Johnson B., Roque E., Green M., Loewenstein P., Oldfield E. H., Kleinman H. K. Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domain. J. Neurosci. Res. 42:1995;34-40.
436. Weller R. O., Engelhardt B., Phillips M. J. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol. 6:1996;275-288.
437. Wesselingh S. L., Power C., Glass J. D., Tyor W. R., McArthur J. C., Farber J. M., Griffin J. W., Griffin D. E. Intracerebral cytokine mRNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33:1993;576-582.
438. Wesselingh S. L., Glass J., McArthur J. C., Griffin J. W., Griffin D. E. Cytokine dysregulation in HIV-associated neurological disease. Adv. Neuroimmunol. 4:1994;199-206.
439. Willenborg D. O., Fordham S., Bernard C. A., Cowden W. B., Ramshaw I. A. IFN-γ plays a critical down regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223-3227.
440. Willenborg D. O., Staykova M. A., Miyasaka M. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity. J. Immunol. 157:1996;1973-1980.
441. Wilson A. G., diGiovine F. S., Duff G. W. Genetics of tumor necrosis factor-α in autoimmune, infectious and neoplastic diseases. J. Inflamation. 45:1995;1-12.
442. Wingerchuk D., Liu Q., Sobell J., Sommer S., Weinshenker B. G. A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis. Neurology. 49:1997;626-628.
443. Woolf C. J., Allchorne A., Dsagfieh-Garabedian B., Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumor necrosis factor α Br. J. Pharmac. 121:1997;417-424.
444. Wong G. H. W., Barlett P. F., Clark-Lewis I., Bartye F., Schrader J. W. Inducible expression of H-2 and Ia antigens on brain cells. Nature. 310:1984;688-691.
445. Wu E., Dickson D. W., Jacobson S., Raine C. S. Neuroaxonal dystrophy in HTLV-I associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations. Acta Neuropathol. 86:1993;224-235.
446. Wu Y. Y., Bradshaw R. A. Synergestic induction of neurite outgrowth by nerve growth factor or epidermal growth factor and interleukin-6 in PC12 cells. J. Biol. Chem. 271:1996;13033-13039.
447. Yamasu K., Onoe H., Soma G., Oshima H., Mizuno D. Secretion of tumor necrosis factor during fetal and neonatal development of the mouse: ontogenic inflammation. J. Biol. Response Mod. 8:1989;644-655.
448. Yankner B. A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
449. Yednock T. A., Cannon C., Fritz L. C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha-4-beta-1 integrin. Nature. 356:1992;63-66.
450. Yong V. W., Moumdjian R., Yong F. P., Ruijs T. C., Freeman M. S., Cashman N., Antel J. P. Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc. natl Acad. Sci. U.S.A. 88:1991;7016-7020.
451. Yun H. Y., Dawson V. L., Dawson T. M. Neurobiology of nitric oxide. Crit. Rev. Neurobiol. 10:1996;291-316.
452. Zamvil S. S., Steinman L. The T-lymphocyte in experimental allergic encephalomyelitis. A. Rev. Immunol. 8:1990;579-621.
453. Zielasek J., Tausch M., Toyka K. V., Hartung H. P. Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell. Immunol. 141:1992;111-120.
454. Zielasek J., Jung S., Gold R., Liew F. Y., Toyka K. V., Hartung H. P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis andexperimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;81-88.